Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sven Perner

Showing results (181-190 of 283) with videos related to

Pageof 29
Sort By:
Head & Neck|February 27, 2016
Targeting irradiation-induced mitogen-activated protein kinase activation in vitro and in an ex vivo model for human head and neck cancerAnnette Affolter, Marie-France Muller, Katharina Sommer, et al.
Journal of Cellular and Molecular Medicine|December 2, 2008
Clinical significance of TTF-1 protein expression and TTF-1 gene amplification in lung adenocarcinomaJustine A Barletta, Sven Perner, A John Iafrate, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|June 1, 2013
SOX2 expression and prognostic significance in ovarian carcinomaDeborah L Pham, Veit Scheble, Petra Bareiss, et al.
Lung Cancer (Amsterdam, Netherlands)|April 12, 2011
Frequency and clinicopathologic correlates of KRAS amplification in non-small cell lung carcinomaPatrick L Wagner, Ann-Cathrin Stiedl, Theresia Wilbertz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2008
Characterization of TMPRSS2-ERG fusion high-grade prostatic intraepithelial neoplasia and potential clinical implicationsJuan-Miguel Mosquera, Sven Perner, Elizabeth M Genega, et al.
Frontiers in Medicine|May 14, 2021
Performance of Different Diagnostic PD-L1 Clones in Head and Neck Squamous Cell CarcinomaJulika Ribbat-Idel, Franz F Dressler, Rosemarie Krupar, et al.
International Journal of Molecular Sciences|November 11, 2022
The Gene Expression Landscape of Prostate Cancer BM Reveals Close Interaction with the Bone MicroenvironmentAlireza Saraji, Kang Duan, Christian Watermann, et al.
Frontiers in Oncology|January 9, 2019
Expression of Prostate-Specific Membrane Antigen (PSMA) on Biopsies Is an Independent Risk Stratifier of Prostate Cancer Patients at Time of Initial DiagnosisMarie Christine Hupe, Christian Philippi, Doris Roth, et al.
Neoplasia (New York, N.Y.)|January 30, 2013
Concurrent AURKA and MYCN gene amplifications are harbingers of lethal treatment-related neuroendocrine prostate cancerJuan Miguel Mosquera, Himisha Beltran, Kyung Park, et al.
Oncotarget|July 5, 2016
The activation of OR51E1 causes growth suppression of human prostate cancer cellsDésirée Maßberg, Nikolina Jovancevic, Anne Offermann, et al.
Pageof 29

Showing results (181-190 of 283) with videos related to

Sort By:
Pageof 29
Head & Neck|February 27, 2016
Targeting irradiation-induced mitogen-activated protein kinase activation in vitro and in an ex vivo model for human head and neck cancerAnnette Affolter, Marie-France Muller, Katharina Sommer, et al.
Journal of Cellular and Molecular Medicine|December 2, 2008
Clinical significance of TTF-1 protein expression and TTF-1 gene amplification in lung adenocarcinomaJustine A Barletta, Sven Perner, A John Iafrate, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|June 1, 2013
SOX2 expression and prognostic significance in ovarian carcinomaDeborah L Pham, Veit Scheble, Petra Bareiss, et al.
Lung Cancer (Amsterdam, Netherlands)|April 12, 2011
Frequency and clinicopathologic correlates of KRAS amplification in non-small cell lung carcinomaPatrick L Wagner, Ann-Cathrin Stiedl, Theresia Wilbertz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2008
Characterization of TMPRSS2-ERG fusion high-grade prostatic intraepithelial neoplasia and potential clinical implicationsJuan-Miguel Mosquera, Sven Perner, Elizabeth M Genega, et al.
Frontiers in Medicine|May 14, 2021
Performance of Different Diagnostic PD-L1 Clones in Head and Neck Squamous Cell CarcinomaJulika Ribbat-Idel, Franz F Dressler, Rosemarie Krupar, et al.
International Journal of Molecular Sciences|November 11, 2022
The Gene Expression Landscape of Prostate Cancer BM Reveals Close Interaction with the Bone MicroenvironmentAlireza Saraji, Kang Duan, Christian Watermann, et al.
Frontiers in Oncology|January 9, 2019
Expression of Prostate-Specific Membrane Antigen (PSMA) on Biopsies Is an Independent Risk Stratifier of Prostate Cancer Patients at Time of Initial DiagnosisMarie Christine Hupe, Christian Philippi, Doris Roth, et al.
Neoplasia (New York, N.Y.)|January 30, 2013
Concurrent AURKA and MYCN gene amplifications are harbingers of lethal treatment-related neuroendocrine prostate cancerJuan Miguel Mosquera, Himisha Beltran, Kyung Park, et al.
Oncotarget|July 5, 2016
The activation of OR51E1 causes growth suppression of human prostate cancer cellsDésirée Maßberg, Nikolina Jovancevic, Anne Offermann, et al.
Pageof 29